Phio Pharmaceuticals Corp. (PHIO)
NasdaqCM - NasdaqCM 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 0.8793 |
| 開市 | 0.9100 |
| 買盤 | 0.8121 x 100 |
| 賣出價 | 0.8573 x 100 |
| 今日波幅 | 0.8120 - 0.9200 |
| 52 週波幅 | 0.5000 - 6.8500 |
| 成交量 | |
| 平均成交量 | 432,259 |
| 市值 | 3.84M |
| Beta 值 (5 年，每月) | 1.42 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -5.2000 |
| 業績公佈日 | 2024年5月09日 - 2024年5月13日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 4.00 |
BenzingaWhy Are Phio Pharmaceuticals Shares Trading Higher Today
Phio Pharmaceuticals Corp (NASDAQ: PHIO) shares are gaining after the FDA cleared its Investigational New Drug (IND) application to proceed with a clinical trial of Phio's lead product candidate, PH-762. PH-762 is an INTASYL compound that reduces the expression of PD-1, a protein that inhibits T cells' ability to kill cancer cells. Phio plans to initiate its Phase 1b clinical trial of intratumoral PH-762 in patients with cutaneous squamous cell carcinoma, melanoma, and Merkel cell in the second
